Cash & equivalents decreased 23.3%
Cash & equivalents changed -23.3% from the comparable as-filed period.
$8.5M→$6.5M1 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -23.3% from the comparable as-filed period.
Net income changed +15.2% from the comparable as-filed period.
Inventory changed -2.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.